Sanofi to announce COVID vaccine price in development with GSK post Phase 1, 2 trial results
Paris: French drug maker Sanofi will announce the price of the potential COVID-19 vaccine it is developing with Britain's GlaxoSmithKline after it has released Phase I/II results of the trials, vaccines chief Thomas Triomphe said on Thursday.The company is expected to release the results from the Phase I/II clinical trials this month.Read also: Ten COVID vaccines could be available by...
Paris: French drug maker Sanofi will announce the price of the potential COVID-19 vaccine it is developing with Britain's GlaxoSmithKline after it has released Phase I/II results of the trials, vaccines chief Thomas Triomphe said on Thursday.
The company is expected to release the results from the Phase I/II clinical trials this month.
Read also: Ten COVID vaccines could be available by mid-year: Head of global pharma group
It is also developing a vaccine with U.S. biotech firm Translate Bio, with clinical human trials expected to start this month.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd